Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06438315 · ClinicalTrials.gov registry record
SuperSaturated Oxygen Comprehensive Observational Registry
A clinical trial of STEMI - ST Elevation Myocardial Infarction and AMI, sponsored by TherOx.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 20
- Study locations
NCT06438315 is a study of STEMI - ST Elevation Myocardial Infarction and AMI that is actively recruiting participants, run by TherOx. The registered enrollment target is 1,000 participants. The trial reports 20 study locations across 8 states.
The verdict
NCT06438315, a study of STEMI - ST Elevation Myocardial Infarction and AMI, is actively recruiting participants, sponsored by TherOx.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 20
- Study locations
Study Summary
The SuperSaturated Oxygen Comprehensive Observational Registry (SSCORE) registry, a prospectively designed observational study, aims to evaluate the clinical utility and effectiveness of SuperSaturated Oxygen (SSO2) Therapy versus percutaneous coronary intervention (PCI) alone among patients with anterior acute myocardial infarction (AMI) in routine clinical practice. The goal is to collect real-world data from patients treated with SSO2 Therapy to determine its impact on the overall heart failure (HF) burden on patients and healthcare systems compared with usual care for treatment of patients with AMI. The SSCORE Registry will generate effectiveness and healthcare resource utilization data that will be used in cost-effectiveness analysis modeling.
Conditions Studied
Interventions
- OTHER No intervention
Study Locations (20)
California
- MemorialCare Orange Coast Medical Center - Fountain Valley
- UCSD Health La Jolla - Sulpizio Cardiovascular Center - La Jolla
- MemorialCare Saddleback Medical Center - Laguna Hills
- MemorialCare Long Beach Medical Center - Long Beach
- UCSD Hillcrest Medical Center - San Diego
Florida
- Baptist Health Baptist Hospital - Miami
- NCH Baker Hospital - Naples
- NCH North Naples - Naples
Minnesota
- Mercy Hospital - Coon Rapids
- Abbott Northwestern Hospital - Minneapolis
- United Hospital - Saint Paul
New Jersey
- RWJ- Jersey City Medical Center - Jersey City
- Robert Wood Johnson University Hospital - New Brunswick
- Newark Beth Israel Medical Center - Newark
Illinois
- University of Chicago - Chicago
- Carle Health Methodist Hospital - Peoria
New York
- North Shore University Hospital - Manhasset
- Long Island Jewish Hospital - Queens
Kansas
- Ascension Via Christi St Francis - Wichita
Michigan
- Corewell Health Dearborn Hospital - Dearborn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2024-08-13 |
| Est. Completion | 2029-03-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06438315
The ClinicalTrials.gov registry entry for NCT06438315 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is TherOx, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with STEMI - ST Elevation Myocardial Infarction appearing as the primary indexed condition, and to 1 intervention - of which No intervention is the first listed.
NCT06438315 reports 20 study locations spanning 8 distinct geographic areas - top geographies include California, Florida, Minnesota.
Frequently Asked Questions
What is clinical trial NCT06438315 about?
NCT06438315 is a clinical study titled "SuperSaturated Oxygen Comprehensive Observational Registry". The SuperSaturated Oxygen Comprehensive Observational Registry (SSCORE) registry, a prospectively designed observational study, aims to evaluate the clinical utility and effectiveness of SuperSaturated Oxygen (SSO2) Therapy versus percutaneous coronary intervention (PCI) alone among patients with an...
What is the current status of trial NCT06438315?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2024-08-13. Estimated completion is 2029-03-31.
What conditions does trial NCT06438315 study?
This clinical trial studies the following conditions: STEMI - ST Elevation Myocardial Infarction, AMI.
What interventions are being tested in trial NCT06438315?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT06438315?
This trial is sponsored by TherOx, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06438315 being conducted?
This trial has 20 study locations across California, Florida, Illinois, Kansas, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for STEMI - ST Elevation Myocardial Infarction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.